首页> 美国卫生研究院文献>BMC Cancer >A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey

【2h】

A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey

机译：RTOG 9802之后德国第三中心的低级神经胶质瘤更趋于辅助治疗的趋势–多中心调查的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe treatment recommendations for Low-grade Gliomas (LGG) underwent profound changes due to results from RTOG 9802 published in April 2016. This work aims to investigate whether the results from the trial were already incorporated into the treatment recommendations at German oncology centers before an update of the official guidelines.

机译：背景由于2016年4月发布的RTOG 9802的结果，低级胶质瘤（LGG）的治疗建议发生了深刻的变化。这项工作旨在调查该试验的结果是否已在更新之前已纳入德国肿瘤学中心的治疗建议中。官方指南。

著录项

期刊名称 BMC Cancer
作者
Christoph Straube; Kerstin A. Kessel; Friederike Schmidt-Graf; Sandro M. Krieg; Bernhard Meyer; Jens Gempt; Stephanie E. Combs;
展开▼
作者单位

展开▼
年(卷),期 2018(18),-1
年度 2018
页码 907
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey [J] . Christoph Straube, Kerstin A. Kessel, Friederike Schmidt-Graf, BMC Cancer . 2018,第1期

机译：RTOG 9802之后，德国高级中心在德国高级胶质瘤的趋势趋势 - 来自多中心调查的结果
2. Practice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma [J] . Martin J. van den Bent Neuro-Oncology . 2014,第12期

机译：实践改变RTOG研究9802的成熟结果：另一项PCV阳性试验使辅助化疗成为低度神经胶质瘤护理标准的一部分
3. Is guideline-adherent adjuvant treatment an equal alternative for patients aged > 65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients [J] . Van Ewijk R., Woeckel A., Gundelach T., Archives of gynecology and obstetrics. . 2015,第3期

机译：对于不能参加辅助性临床乳腺癌试验的65岁以上的患者，是否坚持指南辅助治疗是同等的选择？一项对4,142名患者的回顾性多中心队列研究
4. Treatment Practice Analysis of Intermediate or High Risk Localized Prostate Cancer: A Multi-center Study with Veterans Health Administration Data [C] . Khajamoinuddin Syed, William Sleeman IV, Joseph Nalluri, International Conference on Computational Advances in Bio and Medical Sciences . 2019

机译：中度或高危局限性前列腺癌的治疗实践分析：采用退伍军人卫生管理数据的多中心研究
5. Clinically useful measures of effects of treatment and exposure from binary multi-center data. [D] . Localio, A. Russell. 2005

机译：来自二进制多中心数据的治疗和暴露效果的临床有用度量。
6. RTHP-23. ADJUVANT THERAPY FOR HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA AFTER RTOG 9802: A SURVEY OF CURRENT PRACTICE [O] . Mohamad Fakhreddine, Anand Parameswaran, John Floyd, 2017

机译：RTHP-23。 RTOG 9802后高危II级少突胶质瘤的辅助治疗：当前实践调查
7. A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey [O] . Christoph Straube, Kerstin A. Kessel, Friederike Schmidt-Graf, 2018

机译：RTOG 9802之后，德国高级中心在德国高级胶质瘤的趋势趋势 - 来自多中心调查的结果

A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 – results from a multi-center survey

摘要

著录项

相似文献

相关主题

期刊订阅